Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment
-- New collaboration follows previous Lilly and Nimbus AMPK research collaboration in cardiometabolic disease -- BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus...
